About ReCell®
ReCell® is an innovative single-use medical device for harvesting autologous skin cells. Developed as an 'off the shelf' kit, ReCell® enables a thin split thickness biopsy, taken at the time of procedure, to be processed into an immediate cell population for delivery onto the wound surface.
ReCell® enables the delivery of keratinocytes, melanocytes, fibroblasts and Langerhans cells harvested from the epidermal-dermal junction for application onto a wound surface in order to promote effective wound healing. Melanocyte repopulation may result in the reintroduction of pigmentation into hypopigmented regions.
ReCell® has been generally used to treat smaller wounds such as small burns and scalds, donor sites, glabrous injuries, congenital nevi, hypopigmentation (hypopigmented scars, iatrogenic hypopigmentation and Vitiligo), chronic wounds and prophylactically in cosmetic rejuvenation procedures.
Once processed, the cell suspension is available for immediate use and can cover a wound many times the area of the donor biopsy. As the ReCell® device enables cell processing at the site of treatment without the use of specialised laboratory staff, the process is both cost and time efficient.
Advantages include:
- Improved wound healing time and scar quality.
- Repopulation of melanocytes to reduce hypopigmentation.
- On-site processing for immediate application.
- Increased viability through immediate harvest and application.
- Ability to be processed by clinician not specialised laboratory staff.
Find out about upcoming ReCell workshops.
